[:el]The CVI leadership is excited to announce that
next year’s event will include presentations
from leaders of major pharmaceutical companies,
federal and foundation policy makers,
and scientists making groundbreaking
advances in the drug discovery space. Highlights
include: the presentation of a Lifetime
Achievement Award to Dr. Roy Vagelos (former
CEO of Merck and current Chair of Regeneron);
a Keynote Address from Dr. Brian Kobilka (Nobel Prize in Chemistry, 2012); a Fireside
Chat with Stanford University President Marc Tessier-Lavigne, PhD, and Stanford School
of Medicine Dean Lloyd Minor, MD; a panel discussion with editors representing the New
England Journal of Medicine, JAMA, Science, and Nature Reviews Drug Discovery; and View
from the Top presentations by biotechnology industry leaders Ken Frazier (CEO of Merck),
Bob Bradway (CEO of Amgen) Joe Jimenez (Former CEO of Novartis), Jeff Leiden (CEO of
Vertex), Patrick Soon-Shiong (CEO of Nantworks), and George Scangos (CEO of Vir).
In addition, researchers engaged in clinical and translational stage projects will have the
opportunity to present their ideas in an interactive shark-tank style competition judged by
a panel of CEOs.[:]